Performance of BGNE BeiGene | -32.4% in 12m
Compare BGNE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare BeiGene with its related Sector/Index XBI
Performance Duell BGNE vs XBI
| TimeFrame | BGNE | XBI |
|---|---|---|
| 1 Day | -4.45% | -0.94% |
| 1 Week | -0.83% | -2.69% |
| 1 Month | 14.0% | -0.01% |
| 3 Months | 9.93% | -5.33% |
| 6 Months | -19.0% | 31.03% |
| 12 Months | -32.4% | 3.19% |
| YTD | -8.97% | -2.32% |
| Rel. Perf. 1m | 1.20 | |
| Rel. Perf. 3m | -0.77 | |
| Rel. Perf. 6m | -4.23 | |
| Rel. Perf. 12m | -4.42 |
Is BeiGene a good stock to buy?
No, based on ValueRay Fundamental Analyses, BeiGene (NASDAQ:BGNE) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -50.45 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of May 2024 is 139.27. This means that BGNE is currently overvalued and has a potential downside of -13.57% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of May 2024 is 139.27. This means that BGNE is currently overvalued and has a potential downside of -13.57% (Sold with Premium).
Is BGNE a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: BGNE is performing better - Values below 0%: BGNE is underperforming
Compare BGNE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.66% | 12.07% | -38.14% | -60.78% |
| US NASDAQ 100 | QQQ | -1.24% | 13.17% | -36.61% | -69.31% |
| US Dow Jones Industrial 30 | DIA | -2.56% | 9.95% | -35.07% | -53.30% |
| German DAX 40 | DBXD | -3.94% | 9.64% | -40.91% | -49.86% |
| UK FTSE 100 | ISFU | -2.11% | 7.64% | -36.90% | -45.76% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.59% | 7.33% | -21.62% | -23.91% |
| Hongkong Hang Seng | HSI | -3.24% | -0.81% | -22.88% | -23.59% |
| Japan Nikkei 225 | EXX7 | 1.77% | 18.98% | -31.80% | -45.96% |
| India NIFTY 50 | INDA | 1.08% | 14.61% | -34.62% | -56.96% |
| Brasil Bovespa | EWZ | 1.40% | 12.94% | -20.21% | -44.95% |
BGNE BeiGene vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.43% | 13.46% | -39.30% | -70.65% |
| Consumer Discretionary | XLY | 0.12% | 13.47% | -29.28% | -53.81% |
| Consumer Staples | XLP | -3.07% | 8.25% | -32.85% | -35.99% |
| Energy | XLE | -1.40% | 16.42% | -32.64% | -56.03% |
| Financial | XLF | -2.68% | 9.61% | -43.58% | -65.87% |
| Health Care | XLV | -2.38% | 10.66% | -32.95% | -42.81% |
| Industrial | XLI | -2.18% | 11.77% | -42.47% | -62.16% |
| Materials | XLB | -2.80% | 11.89% | -39.12% | -52.41% |
| Real Estate | XLRE | -2.94% | 12.50% | -31.79% | -37.98% |
| Technology | XLK | -1.13% | 13.97% | -34.58% | -69.67% |
| Utilities | XLU | -4.48% | 3.02% | -40.67% | -39.20% |
| Aerospace & Defense | XAR | -1.15% | 7.72% | -35.28% | -59.37% |
| Biotech | XBI | 1.86% | 14.04% | -50.00% | -35.59% |
| Homebuilder | XHB | -1.44% | 10.89% | -58.68% | -85.54% |
| Retail | XRT | -0.96% | 10.55% | -44.98% | -56.61% |
Does BeiGene outperform its market, is BGNE a Sector Leader?
No, over the last 12 months BeiGene (BGNE) made -32.40%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.19%.
Over the last 3 months BGNE made 9.93%, while XBI made -5.33%.
No, over the last 12 months BeiGene (BGNE) made -32.40%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.19%.
Over the last 3 months BGNE made 9.93%, while XBI made -5.33%.
| Period | BGNE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 14.03% | -0.01% | 1.96% |
| 3 Months | 9.93% | -5.33% | 4.29% |
| 12 Months | -32.40% | 3.19% | 28.38% |